Regulatory Compliance, Trade Implications 16 Jan 2025 agriculture, usda, import regulations, animal health, nicaragua, screwworm

🚫Nicaragua Added to Screwworm List

We are advising the public that we have added Nicaragua to the Animal and Plant Health Inspection Service (APHIS) list maintained on the APHIS website of regions considered affected with screwworm. We took this action because of the confirmation of screwworm in this region.

Learn More
Compliance, Consumer Trends, Regulatory Information 16 Jan 2025 regulations, fda, animal health, cannabis, cbd, veterinary medicine

🐾FDA Seeks Input on Cannabis-Derived Products in Veterinary Use

The Food and Drug Administration (FDA, the Agency, or we) is soliciting comments from the public, particularly veterinarians, related to the use of cannabis-derived products (CDPs) in animals, with an emphasis on cannabidiol (CBD) products and general trends associated with those products, including information about: usage trends (e.g., product selection, indications, etc.), quality standards, benefits of use, potential drug interactions, adverse events and safety problems, and toxicological concerns. This information will enhance the Center for Veterinary Medicine's (CVM's) knowledge of potential safety signals associated with these products, in addition to aiding our understanding of veterinarians' experiences related to the use of CDPs for their animal patients.

Learn More
Regulation, Compliance, Research & Development 7 Jan 2025 regulations, fda, biotechnology, veterinary, animal health

🐾FDA Guidance on Type VII Veterinary Master Files for R&D Released

The Food and Drug Administration (FDA, Agency, or we) is announcing the availability of a draft guidance for industry (GFI) #260 entitled "Type VII Veterinary Master File for Research and Development and Risk Reviews." This draft guidance, when finalized, will describe FDA's current thinking regarding the use of Type VII Veterinary Master Files (Type VII VMFs). Type VII VMFs are appropriate for research and development of animal cells, tissues, and cell- and tissue-based products (ACTPs), gene therapies, and heritable intentional genomic alterations (IGAs) in animals.

Learn More